The largest comparison of tau pathology in early- and late-onset Alzheimer’s included 390 participants whose symptoms began before age 65 and 211 with later-onset disease. Tau PET scans, which reveal the amount and location of abnormal tau deposits, showed more extensive pathology in…
BioPharm International Spyre Therapeuticsâ half-life-extended anti-TL1A antibody SPY072 failed to meet its primary endpoints in psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) in the Phase 2 SKYWAY basket trial, and the company will no longer develop the antibody in rheumatic diseases.¹ Spyre…
As people are able to live longer on average, the goal has become to make the most of those extra years. Local longevity clinics and wellness spas are hoping to help to make that happen. Wave Wellness is set to…
A Korean two-stage sequencing study found that Non-APOE candidate variants added almost no predictive power once leakage and APOE effects were removed. News Source: Juliet Wilcox. (October 29, 2026). Machine learning finds Non-APOE gene signals too weak to predict Alzheimer’s. Scienmag.
Waiting times for an initial neurology appointment for memory concerns average more than 4 months, potentially delaying diagnosis and treatment. In a nationwide telephone survey of 150 neurology clinics nationwide, researchers found that wait times averaged 21.1 weeks at specialized centers and 15.6 weeks…
Researchers have traced how the molecular byproducts of active DNA demethylation change across the human lifespan, comparing measurements in urine with measurements in DNA extracted from leukocytes. The study, published as a research article in Biological Research, analyzed samples from…
Springer Nature's 2026 Editor of Distinction Awards recognize thirty BMC Geriatrics editors for rigorous peer review management and exceptional service to authors.
Moe Alsumidaie, MBA, MSF, is founder and Chief Editor of Vanguard Publications, which publishes Clinical Trial Vanguard, Pharma Vanguard and BullScope, and Head of Research at CliniBiz. He has two decades in clinical trial operations and data science, with earlier…
The Health Ministry has established a specialized 27-member legislative drafting committee tasked with creating a comprehensive and modern regulatory framework for medical and nonmedical antiaging and longevity practices, services that currently remain entirely unregulated across the nation. This regulatory initiative…
Argent plans to extend its immune-modulation expertise into healthy ageing research. Pic: Getty Images Argent BioPharma (ASX:RGT) has listed four strategic priorities following the global licensing of CannEpil, expansion of its pharmaceutical development programs and continued advancement of its…
Longevity Clinics and Tests in Longevity: the news, the names and what changed.
An article joins this feed when it matches these terms. Each one is also a search of its own.